E-LIB Suche - Ergebnisse für: Kerchner, Geoffrey

1

Evaluation of partial volume correction and analysis of lon..:

Sanabria Bohórquez, Sandra M. ; Baker, Suzanne ; Manser, Paul T....
Frontiers in Neuroimaging. 3 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Prasinezumab slows motor progression in rapidly progressing..:

Pagano, Gennaro ; Taylor, Kirsten I. ; Anzures Cabrera, Judith...
Nature Medicine. 30 (2024) 4 - p. 1096-1103 , 2024

Link: https://doi.org/10.1038/..

3

Comprehensive proteomics of CSF, plasma, and urine identify..:

Rutledge, Jarod ; Lehallier, Benoit ; Zarifkar, Pardis...
Acta Neuropathologica. 147 (2024) 1 - p. , 2024

Link: https://doi.org/10.1007/..

4

Multiple biomarkers improve diagnostic accuracy across Lewy..:

Plastini, Melanie J. ; Abdelnour, Carla ; Young, Christina B....
Annals of Clinical and Translational Neurology. 11 (2024) 5 - p. 1197-1210 , 2024

Link: https://doi.org/10.1002/..

5

Plasma pTau181 Reveals a Pathological Signature that Predic..:

Abdelnour, Carla ; Young, Christina B. ; Shahid‐Besanti, Marian...
Annals of Neurology. , 2024

Link: https://doi.org/10.1002/..

6

Using plasma ptau181 in Lewy Body Disease spectrum for the ..:

Abdelnour, Carla ; Shahid, Marian ; Smith, Alena...
Alzheimer's & Dementia. 19 (2023) S14 - p. , 2023

Link: https://doi.org/10.1002/..

7

Exploratory Delayed-Start Analysis Of PASADENA Part 3 52-We..:

Pagano, Gennaro ; Zanigni, Stefano ; Monnet, Annabelle...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

8

Associations of APOE4 and Alzheimer's disease biomarkers wi..:

Trelle, Alexandra N ; Wilson, Edward N. ; Romero, America...
Alzheimer's & Dementia. 19 (2023) S15 - p. , 2023

Link: https://doi.org/10.1002/..

9

Decision making in clinical trials: Interim analyses, innov..:

Welsh‐Bohmer, Kathleen A. ; Kerchner, Geoffrey A. ; Dhadda, Shobha...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 9 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

10

Open RoAD: Design and baseline characteristics of an open‐l..:

Neve, Anuja ; Bullain, Szofia ; Das, Bibha...
Alzheimer's & Dementia. 19 (2023) S7 - p. , 2023

Link: https://doi.org/10.1002/..

11

A 104-week delayed-start analysis of PASADENA (Phase II stu..:

Pagano, Gennaro ; Zanigni, Stefano ; Monnet, Annabelle...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

12

PostGraduate Open-label Rollover Study: Evaluation of Subcu..:

Lane, Christopher ; Thanasopoulou, Angeliki ; Delmar, Paul...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

13

Baseline Characteristics of the GRADUATE Studies: Phase III..:

Lane, Christopher ; Bullain, Szofia ; Thanasopoulou, Angeliki...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

14

A Phase 1 study of GDC‐0134, a dual leucine zipper kinase i..:

Katz, Jonathan S. ; Rothstein, Jeffrey D. ; Cudkowicz, Merit E....
Annals of Clinical and Translational Neurology. 9 (2022) 1 - p. 50-66 , 2022

Link: https://doi.org/10.1002/..

15

Gantenerumab treatment increases plasma beta‐amyloid(1–42) ..:

Bittner, Tobias ; Scelsi, Marzia A. ; Kollmorgen, Gwendlyn...
Alzheimer's & Dementia. 18 (2022) S5 - p. , 2022

Link: https://doi.org/10.1002/..